摘要
神经退行性疾病的病理生理状况无疑与蛋白质错误折叠有关。错误折叠的蛋白质积累成相对有序的结构,如纤维状细胞内和细胞外淀粉样蛋白,导致组织损伤,从而导致神经元丢失和脑损伤。在这些病理中,蛋白质聚集体的出现表明那些应该适当地协助客户蛋白质折叠的分子伴侣的某些低效或不充分的细胞反应。在这方面,大多数神经退行性疾病的实验模型已经证明分子伴侣的过度表达提供了有效的神经保护。这些分子伴侣的一个子集对应于一组具有肽基脯氨酰异构酶酶活性的蛋白质,即亲免素。后一组的大多数家族成员首先被描述为负责免疫抑制反应,或者他们被报道为与类固醇受体寡聚体中的 HSP90 相关的伴侣复合物的成员。在这篇文章中,我们回顾了分子伴侣与神经退行性疾病之间联系的一些方面,特别是热休克蛋白和亲免蛋白,它们对线粒体的正常功能有影响。本文旨在解决一个领域,该领域代表了一个尚未满足的临床需求,即开发专注于潜在新分子靶点的神经保护分子。
关键词: 亲免蛋白、神经变性、HSP90、FKBP51、FKBP52、亲环蛋白 A。
图形摘要
Current Drug Targets
Title:Role of Mitochondrial Heat-shock Proteins and Immunophilins in Neuro Degenerative Diseases
Volume: 22 Issue: 14
关键词: 亲免蛋白、神经变性、HSP90、FKBP51、FKBP52、亲环蛋白 A。
摘要: Pathophysiologic conditions of neurodegenerative diseases are unquestionably related to protein misfolding. The accumulation of misfolded proteins into relatively ordered structures such as fibrillar intracellular and extracellular amyloids results in tissue lesions that lead to neuronal loss and brain damage. In these pathologies, the occurrence of protein aggregates suggests certain inefficient or insufficient cellular responses of those molecular chaperones that should properly assist the folding of the client proteins. In this regard, most experimental models for neurodegenerative diseases have demonstrated that the overexpression of molecular chaperones provides effective neuroprotection. A subset of these molecular chaperones corresponds to a group of proteins that exhibit peptidylprolyl isomerase enzymatic activity, the immunophilins. Most of the family members of the latter group were first described as being responsible for the immunosuppressive response or they were reported as members of the chaperone complex associated with HSP90 in steroid receptor oligomers. In this article, we review some aspects of the liaison between molecular chaperones and neurodegenerative diseases, in particular heat-shock proteins and immunophilins with demonstrated influence on the proper function of mitochondria. This article is intended to address a field that represents a yet critical unmet clinical need for the development of neuroprotective molecules focused on potentially novel molecular targets.
Export Options
About this article
Cite this article as:
Role of Mitochondrial Heat-shock Proteins and Immunophilins in Neuro Degenerative Diseases, Current Drug Targets 2021; 22 (14) . https://dx.doi.org/10.2174/1389450121999201230204320
DOI https://dx.doi.org/10.2174/1389450121999201230204320 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Optimising the Azeotropic Drying of 18F-Fluorine Wayto Improve the 18F-Fluorocholine Radiochemical Yield
Current Radiopharmaceuticals Exploiting Innate γδ T Lymphocytes for Tumor Immunotherapy
Recent Patents on Biomarkers A Review of Surgical Options to Preserve Fertility in the Treatment of Early Cervical Cancer
Current Women`s Health Reviews Indoleamine 2,3-Dioxygenase, an Emerging Target for Anti-Cancer Therapy
Current Cancer Drug Targets SJSZ Glycoprotein (38 kDa) Inhibits Cell Cycle and Oxidative Stress in N-Methyl-N`- nitro-N-nitrosoguanidine-induced ICR Mice
Anti-Cancer Agents in Medicinal Chemistry Antinociceptive Effects of VV-Hemorphin-5 Peptide Analogues Containing Amino phosphonate Moiety in Mouse Formalin Model of Pain
Protein & Peptide Letters Hypericin Lights Up the Way for the Potential Treatment of Nasopharyngeal Cancer by Photodynamic Therapy
Current Clinical Pharmacology Tumor Stroma as a Target in Cancer
Current Cancer Drug Targets Ceramidases in Hematological Malignancies: Senseless or Neglected Target?
Anti-Cancer Agents in Medicinal Chemistry Law-Medicine Interfacing: Patenting of Human Genes and Mutations
Recent Patents on DNA & Gene Sequences Can Dietary Antioxidants Reduce the Incidence of Brain Tumors?
Current Drug Metabolism Radiosensitizing Effect of Electrochemotherapy: A Systematic Review of Protocols and Efficiency
Current Drug Targets Therapeutic Nucleic Acids
Recent Patents on Regenerative Medicine Tyrosine Kinase Inhibitors
Current Cancer Drug Targets Non-Vitamin K Oral Anticoagulants (NOACs) A Review of Clinical Management and Laboratory Issues
Current Vascular Pharmacology Expression and Function of Kruppel Like-Factors (KLF) in Carcinogenesis
Current Genomics Decreasing the Metastatic Potential in Cancers - Targeting the Heparan Sulfate Proteoglycans
Current Drug Targets Peroxisome Proliferator-Activated Receptor-γ and Its Ligands in the Treatment of Tumors in the Nervous System
Current Stem Cell Research & Therapy Potentials of Polymeric Nanoparticle as Drug Carrier for Cancer Therapy: With a Special Reference to Pharmacokinetic Parameters
Current Drug Metabolism H3K4 Methylation Status and Lysine Specific Methyltransferase KMT2C Expression Correlate with Prognosis in Lung Adenocarcinoma
Current Molecular Pharmacology